Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
67,341,788
-
Total 13F shares
-
62,378,764
-
Share change
-
+2,854,547
-
Total reported value
-
$1,816,485,551
-
Put/Call ratio
-
79%
-
Price per share
-
$29.12
-
Number of holders
-
116
-
Value change
-
+$85,568,575
-
Number of buys
-
66
-
Number of sells
-
37
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM) as of Q4 2022
As of 31 Dec 2022,
RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,378,764 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, FEDERATED HERMES, INC., RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, NEA Management Company, LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
116
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.